These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

760 related items for PubMed ID: 24365582

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    Singh J, Sharma BC, Maharshi S, Puri V, Srivastava S.
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1203-9. PubMed ID: 26716736
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
    Schulz C, Schütte K, Kropf S, Schmitt FC, Vasapolli R, Kliegis LM, Riegger A, Malfertheiner P.
    Trials; 2016 Feb 29; 17(1):111. PubMed ID: 26926775
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.
    Sharma P, Sharma BC, Puri V, Sarin SK.
    Am J Gastroenterol; 2008 Jun 29; 103(6):1406-12. PubMed ID: 18510608
    [Abstract] [Full Text] [Related]

  • 50. Olfactory Function is Affected in Patients with Cirrhosis Depending on the Severity of Hepatic Encephalopathy.
    Heiser C, Haller B, Sohn M, Hofauer B, Knopf A, Mühling T, Freiherr J, Bender M, Tiller M, Schmidt A, Schepp W, Gundling F.
    Ann Hepatol; 2018 Aug 24; 17(5):822-829. PubMed ID: 30145560
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients.
    Giménez-Garzó C, Garcés JJ, Urios A, Mangas-Losada A, García-García R, González-López O, Giner-Durán R, Escudero-García D, Serra MA, Soria E, Felipo V, Montoliu C.
    PLoS One; 2017 Aug 24; 12(2):e0171211. PubMed ID: 28146589
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Minimal hepatic encephalopathy does not impair health-related quality of life in patients with cirrhosis: a prospective study.
    Wunsch E, Szymanik B, Post M, Marlicz W, Mydłowska M, Milkiewicz P.
    Liver Int; 2011 Aug 24; 31(7):980-4. PubMed ID: 21733087
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Predictors of minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P, Sharma BC.
    Saudi J Gastroenterol; 2010 Aug 24; 16(3):181-7. PubMed ID: 20616413
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.